Press release
Urothelial Cancer Treatment Market Share, Trends, Size, Research and Forecast 2019-2025
A full report of Global Urothelial Cancer Treatment Market is available at: https://www.omrglobal.com/industry-reports/urothelial-cancer-treatment-market
Immunotherapy, also called biologic therapy. This therapy is intended to boost the natural immune system to fight cancer. Immunotherapy is of two types, local therapy, and systemic therapy. Bacillus Calmette-Guerin (BCG), a standard Immunotherapy drug, used for the treatment of urothelial cancer. Through the catheter, it is directly placed into the bladder. Interferon (Roferon-A, Intron A, Alferon), another type of Immunotherapy it is combined with BCG for the treatment of urothelial cancer. Some of the major drugs used in Immunotherapy are Atezolizumab (Tecentriq), Avelumab (Bavencio), Durvalumab (Imfinzi), Nivolumab (Opdivo), Pembrolizumab (Keytruda), and others.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/urothelial-cancer-treatment-market
The companies present in the market are focused on developing innovative treatment solutions for urothelial cancer treatment. For instance, in May 2016, the company got FDA approval for its cancer immunotherapy Tecentriq (atezolizumab) for the treatment of a specific type of advanced bladder cancer. Further, in 2017, the FDA granted approval to nivolumab (Opdivo) for the treatment of bladder cancer. This makes nivolumab one of the immune checkpoint inhibitor among 5 inhibitors approved for the treatment of bladder cancer. Such advancement is expected to boost the growth of the global urothelial cancer treatment market in the near future.
Global Urothelial Cancer Treatment Market Segmentation
By Therapy Type
• Chemotherapy
• Immunotherapy
• Others ( Targeted Therapy & Radiation Therapy)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/urothelial-cancer-treatment-market
Global Urothelial Cancer Treatment Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Adaptimmune Therapeutics Plc
• Alligator Bioscience AB
• Amgen, Inc.
• AndroScience Corp.
• AstraZeneca PLC
• Bristol-Myers Squibb Co.
• Eisai Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Johnson & Johnson Service, Inc.
• Merck & Co, Inc.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industries, Ltd.
• Vault Pharma, Inc.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urothelial Cancer Treatment Market Share, Trends, Size, Research and Forecast 2019-2025 here
News-ID: 2071332 • Views: …
More Releases from Orion Market Research
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more…
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance,
• In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for…
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance,
• In June 2022, U.S.…
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment…
More Releases for Immunotherapy
Cancer Immunotherapy Drug Discovery Outsourcing Market
Cancer Immunotherapy Drug Discovery Outsourcing Market is thoroughly, accurate and comprehensively assessed in a report focusing on market dynamics, market competition, regional growth, segment analysis, and key growth strategies. Report buyers will have access to proven market figures including global market size in terms of revenue and volume.
(Get 15% Discount on Buying this Report)
A full report of Global Cancer Immunotherapy Drug Discovery Outsourcing Market is available at: https://www.orionmarketreports.com/cancer-immunotherapy-drug-discovery-outsourcing-market/57424/
The Cancer Immunotherapy…
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses.
The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains…
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells…
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Immunotherapy: Mending Cancer Regimens
1.1 Preface to Cancer Immunotherapy
1.2 Evolution of Cancer Immunotherapy
2. Categorization of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.1.1 Cancer Vaccines
2.1.2 Monoclonal Antibodies
2.2 Non-Specific Cancer Immunotherapy
2.2.1 Adoptive Cell Transfer Immunotherapy
2.2.2 Immune Checkpoint Inhibitors
3. Fundamentals…
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics.
Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being…
Cancer Immunotherapy Market: Increasing Government Support Work in Favor of Canc …
Global Cancer Immunotherapy Market: Snapshot
The global cancer immunotherapy market is expected to experience a very high rate of growth over the coming years, owing to the increase in the number of patients suffering from various types of cancer. In terms of the treatment options for cancer, cancer immunotherapy is expected to make serious headway due to its proven greater efficiency over conventional treatment methods. The market is also expected to…
